US Stock MarketDetailed Quotes

IMNN Imunon

Watchlist
  • 1.640
  • +0.240+17.14%
Close Mar 28 16:00 ET
  • 1.580
  • -0.060-3.66%
Post 19:57 ET
15.42MMarket Cap-759P/E (TTM)

About Imunon Company

Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm is also engaged in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.

Company Profile

SymbolIMNN
Company NameImunon
Listing Date02/08/2008
Founded1982
CEOMr. Michael H. Tardugno
MarketNASDAQ
Employees31
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address997 Lenox Drive,Suite 100
CityLawrenceville
ProvinceNew Jersey
CountryUnited States of America
Zip Code08648
Phone1-609-896-9100

Company Executives

  • Name
  • Position
  • Salary
  • Michael H. Tardugno
  • Executive Chairman of the Board and Chief Executive Officer
  • 2.09M
  • Jeffrey W. Church
  • Executive Vice President and Chief Financial Officer
  • 636.63K
  • Dr. Khursheed Anwer, M.B.A.,PhD
  • Executive Vice President and Chief Scientific Officer
  • 678.66K
  • Constantine J. Kardaras
  • Chief Accounting Officer
  • --
  • Dr. Sebastien Hazard, M.D.
  • Executive Vice President and Chief Medical Officer
  • --
  • James E. Dentzer
  • Independent Director
  • 13.80K
  • Christine A. Pellizzari
  • Independent Director
  • 58.89K
  • Frederick J. Fritz
  • Independent Director
  • 149.96K
  • Dr. Donald Braun, PhD
  • Independent Director
  • 106.26K
  • Dr. Stacy R. Lindborg
  • Independent Director
  • 55.29K
  • Kimberly Bragg
  • Controller
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg